Anxiolytic Peptide
Selank
Tuftsin-Derived Nootropic Research Compound
Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) derived from the immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg). Developed at the Institute of Molecular Genetics in Russia, it has been studied in preclinical models for anxiolytic-like activity, GABAergic system modulation, and neurotrophic factor expression without sedative side effects.
Quantity
10MG
FOR LABORATORY RESEARCH USE ONLY — NOT FOR HUMAN CONSUMPTION
Research Information
- Synthetic analogue of endogenous immunomodulatory peptide tuftsin
- Studied for anxiolytic-like activity via GABAergic and serotonergic pathway modulation
- Investigated for BDNF, NGF, and BDNF-related pathway upregulation
- Research into stable pro-cognitive effects without sedation in animal models
- Complementary research profile to Semax in neuropeptide research paradigms
Storage Conditions
- Long-term: −20°C lyophilised
- Reconstituted: 4°C, use within 28 days
Safe Handling
- For laboratory research use only
- Handle with standard PPE
Frequently Asked
COMPOUND FAQ
Continue Exploring
RELATED COMPOUNDS
Reconstitution Solution
BAC Water
Sterile water for injection containing 0.9% benzyl alcohol as a bacteriostatic preservative. The standard reconstitution vehicle for research peptide compounds.
COMING SOON
Thymic Peptide
Thymosin Alpha-1
A naturally occurring thymic peptide with well-documented immunomodulatory properties, studied extensively in immune regulation and T-cell activation research.
COMING SOON
Nootropic Peptide
Semax
A synthetic heptapeptide analogue of ACTH(4-7) developed for research into neuroprotective mechanisms, BDNF expression, and cognitive function pathways.
RESEARCH USE ONLY: Selank is sold exclusively for in vitro laboratory research. Not intended for human or animal consumption. Not for clinical or therapeutic use.